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Pump thrombosis is a serious complication of continuous-flow left ventricular assist
devices (LVAD). Treatment options include medical thrombolysis, surgical pump
exchange or urgent heart transplantation. We are reporting a case of pump
thrombosis with active hemolysis and acute renal failure managed surgically by
isolating the LVAD while awaiting renal recovery and donor heart availability.
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Case Presentation
A 43 year-old male with end-stage non-ischemic cardiomyopathy underwent
Heartmate II LVAD implantation one year prior as bridge to decision (active
cigarette smoking). Subsequently he required pump exchange for pump
thrombosis at 6 months post-implantation. Two months following pump exchange,
he again developed pump thrombosis and was transferred to our institution for
consideration of urgent heart transplant listing. On arrival he was
hemodynamically stable. Clinical exam demonstrated clear breath sounds
bilaterally, harsh LVAD humming, palpable pulses in all extremities, jugular venous
distension 4 cm above the clavicles and minimal peripheral edema. Urine
revealed gross hemolysis with dark Coca-cola discoloration. Initial lab work
showed an elevated lactate dehydrogenase (LDH) (714 U/L), mildly elevated NT
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pro B-type natriuretic peptide (NT-proBNP) (1046pg/ml ) and serum creatinine of
1.9 mg/dL. Blood count demonstrated hemoglobin of 8 g/dL and hematocrit
25.4%. International normalized ratio (INR) on admission was 1.1 despite warfarin
compliance. ABO blood group was type A, and panel reactive antibody screen
was 0% for class I and class II.
LVAD interrogation revealed high power spikes and low pulsatility index.
Transthoracic echocardiography showed a severely dilated left ventricle (left
ventricular end diastolic diameter 6.8 cm) and left ventricular ejection fraction of
20%. A moderate-sized apical thrombus was identified at the LVAD inflow cannula
(Figure 1). Right heart catheterization demonstrated normal cardiac filling
pressures (central venous pressure 3 mmHg, pulmonary artery pressure 21/8
mmHg, pulmonary capillary wedge pressure 6 mmHg). Fick cardiac output was
measured as 6.11 L/min with cardiac index of 2.8 L/min/m2 and measured mixed
venous oxygen saturation of 49%. Thermodilution cardiac output was measured at
5.57 L/min.

Figure 1a. Apical 4 chamber view of transthoracic echocardiogram showing
the apical thrombus.
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Figure 1b. Zoomed image with the dimension of the thrombus measuring
2.6x1.2 cm.
Intravenous anticoagulation was initiated with heparin infusion for pump
thrombosis and hypercoagulability assessment was performed. Despite
therapeutic heparin anticoagulation, LDH levels continued to rise (3700 U/L) and
the patient developed worsening acute renal injury (serum creatinine 4.37 mg/dL).
Expedited heart transplant evaluation was undertaken, however due to worsening
renal injury he required urgent intervention to eliminate ongoing hemolysis.
Decision was made to isolate the LVAD from circulation and maintain his
hemodynamics with inotropic support. The LVAD outflow graft was isolated and
ligated via subxyphoid incision and the driveline was disconnected from the device
controller. Hemodynamically he remained stable on low dose milrinone infusion,
and heparin anticoagulation was continued for the apical thrombus. Following
outflow graft ligation, urinary discoloration quickly cleared and renal clearance
improved in the following 2 weeks (Figure 2) thereby permitting active listing for
transplant. He was stable without inotropes and subsequently underwent heart
transplantation and LVAD explant 1 week later.
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Figure 2. Creatinine trend from admission day 12/27/2015 till transplant date
1/21/2016. Note that the creatinine level plateaued 12/28 and 12/29, the
patient had LVAD ligation performed 12/29/15, and gradual kidney function
recovery was noticed since.

Discussion
LVAD pump thrombosis is a major complication with increased incidence in recent
years with continuous flow devices. Emphasis has been placed on surgical
technique and cannula malalignment as major contributing factors to the recent
surge in Heartmate II LVAD device thrombosis [1]. Recently, Starling et al [2]
summarized the experience of 3 US centers with 72 confirmed HeartMate II pump
thromboses. A significant 6-month actuarial mortality (48.2%) was noted in those
patients managed medically without heart transplant or pump exchange,
underscoring the importance of surgical intervention. Treatment of pump
thrombosis can include VAD exchange or explant, heart transplantation, or
medical thrombolysis depending on the clinical presentation and patient candidacy
for transplantation [3].
In the case presented, LVAD ligation was felt to be the most feasible option to
eliminate ongoing hemolysis and permit renal recovery for transplant listing,
considering the stable hemodynamics and appearance of adequate cardiac
function on transthoracic echocardiogram. The alternative option of repeat pump
exchange was complicated by the extent of left ventricular thrombus and concern
of cannula malalignment that precipitated the repeated thrombosis. The feasibility
of our approach as a short-term intervention hinged upon our patient being nonsensitized with preformed antibodies thereby facilitating donor heart matching.
LVAD outflow graft ligation has not been previously described for the management
of pump related hemolysis. Baldwin et al [4] described various HeartMate II
explant options in the setting of left ventricular recovery in which the technique of
outflow graft ligation has been successfully demonstrated. Alternatively, driveline
transection also was reported as a surgical option for selected cases in which
LVAD thrombosis occurred during the LVAD weaning process. Consideration of
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this option in our case may also have been well tolerated and resulted in similar
success with elimination of hemolysis as LVAD isolation is similarly accomplished.

Conclusion
In summary, we describe Heartmate II outflow graft ligation (LVAD isolation) and
reversion to medical management of heart failure as a feasible short-term option to
eliminate LVAD associated hemolysis and permit renal recovery.
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